Abiopharma

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024831 <b>Size:</b> 989 KB

(99% Neutral) SENMIAO TECHNOLOGY LTD (AIHS) Announces Executive Changes

(30% Negative) MOVADO GROUP INC (MOV) Reports Q3 2026 Financial Results

Insulet - Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference

(30% Negative) KOHLS CORP (KSS) Reports Q3 2026 Financial Results

Perion Acquires PRN, a Leading In-Store Retail Media Company with Exclusive Multi-year Partnerships Across Some of North America’s Largest Retailers

Insmed to Present at September 2026 Investor Conferences

Polestar Announces Change to Board of Directors

Wayfair Marks Major Milestone with Plans for 10th Store

The J.M. Smucker Co. Announces Fiscal Year 2027 First Quarter Results and Updates Full-Year Fiscal 2027 Outlook

INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings

Sound Group Inc. Reports Unaudited Financial Results for the First Half 2026

Senmiao Technology Limited Announces Name Change to Valor Energy Inc.

LightInTheBox Reports Second Quarter 2026 Financial Results

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases